Character Biosciences Expands Series B Financing to Over $110 Million

Character Biosciences secures over $110 million in Series B funding with involvement from Sanofi Ventures and other investors.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here